星源材質(300568.SZ):擬1億元-2億元回購股份
格隆匯4月16日丨星源材質(300568.SZ)公佈,擬使用自有資金及股票回購專項貸款資金以集中競價交易方式回購公司部分人民幣普通A股股份。在綜合考慮公司財務狀況、經營情況以及未來盈利能力的情況下,本次回購的資金總額不低於10,000萬元(含)且不超過20,000萬元(含),回購股份價格不超過人民幣14元/股,回購股份的實施期限爲自董事會審議通過回購股份方案之日起3個月內;在回購股份價格不超過人民幣14元/股條件下,本次預計回購股份總數約爲7,142,857股至14,285,714股,約佔公司目前總股本的比例爲0.53%至1.06%,具體回購股份的數量以回購期滿時實際回購的股份數量爲準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.